is mounjaro glp 1 agonist (tirzepatide) a dual incretin targeting both GLP-1 and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to GI Adverse Effects of Glucagon-Like
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10

























